• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESHAPE LIFESCIENCES LAP-BAND AP STANDARD W/ ACCESS PORT I; ADJUSTABLE GASTRIC BAND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESHAPE LIFESCIENCES LAP-BAND AP STANDARD W/ ACCESS PORT I; ADJUSTABLE GASTRIC BAND Back to Search Results
Model Number B-2240
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Erosion (1750); Dysphagia/ Odynophagia (1815); Inflammation (1932); Internal Organ Perforation (1987); Pain (1994); Malaise (2359)
Event Date 10/01/2015
Event Type  Injury  
Manufacturer Narrative
Unknown taper.This event was reported by the patient.To date, apollo has been unable to confirm the reported events with the patient's physician.A review of the device labeling notes the following: precautions: over-dissection of the stomach during placement may result in slippage or erosion of the band and require reoperation.Anti-inflammatory agents, which may irritate the stomach, such as aspirin and non-steroidal anti-inflammatory drugs, should be used with caution.The use of such medications may be associated with an increased risk of erosion.Adverse events: it is important to discuss all possible complications and adverse events with your patient.Complications which may result from the use of this product include the risks associated with the medications and methods utilized in the surgical procedure, the risks associated with any surgical procedure and the patient's degree of intolerance to any foreign object implanted in the body.Ulceration, gastritis, gastroesophageal reflux, heartburn, gas bloat, dysphagia, dehydration, constipation, and weight regain have been reported after gastric restriction procedures there is a risk of band erosion into the stomach tissue.Erosion of the band into the stomach tissue has been associated with revision surgery after the use of gastric-irritating medications, after stomach damage and after extensive dissection or use of electrocautery, and during early experience.Symptoms of band erosion may include reduced weight loss, weight gain, access port infection or abdominal pain.Reoperation to remove the device is required.Other adverse events considered related to the lap-band® system that occurred in fewer than 1% of subjects included: esophagitis, gastritis, hiatal hernia, pancreatitis, abdominal pain, hernia, incisional infection, infection, redundant skin, dehydration, gi perforation, diarrhea, abnormal stools, constipation, flatulence, dyspepsia, eructation, cardiospasm, hematemesis, asthenia, fever, chest pain, incision pain, contact dermatitis, abnormal healing, edema, paresthesia, dysmenorrhea, hypochromic anemia, band leak, cholecystitis, esophageal dysmotility, esophageal ulcer, esophagitis, port displacement, port site pain, spleen injury and wound infection.
 
Event Description
Reported as: a patient with the lap-band system reported the device "eroded a hole in the stomach and migrated to the liver." patient noted that after placement they experienced pain and couldn't swallow.Patient was informed that during the placement procedure the physician had filled the band.Patient informed physician that they didn't feel right, had no restrictions with meals.When the physician did a fill the patient couldn't feel it.Although it was noted when the physician removed the fill the same amount of saline was removed that was put in.Patient later had esophagitis.When a physician removed the device it was observed the lap-band was serving as a patch and a hole was noted.The patient had to spend 2-3 days in the hospital to recover from the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND AP STANDARD W/ ACCESS PORT I
Type of Device
ADJUSTABLE GASTRIC BAND
Manufacturer (Section D)
RESHAPE LIFESCIENCES
1001 calle amanecer
san clemente CA 92673
Manufacturer (Section G)
ALLERGAN
global park free zone
900 global park
la aurora de heredia,
CS  
Manufacturer Contact
kristin wielenga
1001 calle amanecer
san clemente, CA 92673
MDR Report Key8709902
MDR Text Key148405439
Report Number3013508647-2019-00034
Device Sequence Number1
Product Code LTI
UDI-Device Identifier10811955020183
UDI-Public10811955020183
Combination Product (y/n)N
PMA/PMN Number
P000008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial
Report Date 05/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/18/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/18/2016
Device Model NumberB-2240
Device Catalogue NumberB-2240
Device Lot Number2653516
Was Device Available for Evaluation? No
Date Manufacturer Received05/20/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/18/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age53 YR
Patient Weight115
-
-